Living with Depression in New York City can feel overwhelming. Between the fast pace, constant noise, and high demands of daily life, the burden of untreated or poorly treated Depression
How TMS Can Reduce Patient Irritability in Depression
Major depressive disorder (MDD) is one of the most prevalent mental health conditions in New York City and across the U.S., affecting millions of adults and significantly impacting quality of
Psilocybin Therapy NYC: Why TMS and Spravato Remain Better Treatment Options
For New York patients living with treatment-resistant Depression (TRD), new therapies can feel like rays of hope breaking through the darkness. The highly publicized clinical trial of psilocybin in the
Precision, Not Price: Effective TMS Coil Placement Doesn’t Require MRI Guidance
Transcranial magnetic stimulation (TMS) has become one of the most effective treatments available for instances of Depression that have not responded to medication. As the technology has advanced, so have
How Esketamine as a Glutamate Depression Treatment is Changing the Landscape of MDD
Major depressive disorder (MDD) is one of the leading causes of disability worldwide, affecting more than 280 million people. While traditional antidepressants have helped millions, about one-third of people with
Benefits of Exercise for Depression: On Movement, Esketamine, and TMS
Depression remains one of the most common and disabling conditions worldwide. Researchers and clinicians increasingly recognize that recovery from Depression is not “one-size-fits-all.” For some, talk therapy and medication provide
Understanding the Spravato Experience: Real Patient Results from the STRIVE Study
Depression is one of the most common mental health conditions in the world. While many people find relief through standard treatments such as oral antidepressants and psychotherapy, a significant number
Breakthrough Spravato Monotherapy Approval for Treatment-Resistant Depression
For many people living with Depression, the path to relief is not straightforward. Traditional antidepressants like SSRIs and SNRIs help millions, but some patients don’t respond at all, even after
Combatting a Low Rate of Long-Term Antidepressant Success with TMS Therapy
For decades, antidepressant medications have been the first-line treatment for major depressive disorder (MDD). While they have helped millions of people, the reality is that they often fall short—with new
Your Spravato Medication Guide: An In-Depth Review for New York City Patients
In New York City, the fast pace and constant pressure can exacerbate Depression—especially for those who’ve tried multiple antidepressants with limited success. That’s why we’ve built out a Spravato medication